XML 138 R122.htm IDEA: XBRL DOCUMENT v3.21.1
Segments of Business - Schedule of Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2019
Segment revenues (1)                      
Revenues $ 59,142 $ 62,599 $ 60,808 $ 55,679 $ 58,535 $ 59,172 $ 57,616 $ 55,728 $ 238,228 $ 231,051 $ 214,319
Operating profit                      
Operating income                 3,828 2,366 1,513
Corporate Expenses, Net                 (8,645) (973) (639)
Interest expense                 (217) (249) (264)
Income (loss) from continuing operations before income taxes                 (5,034) 1,144 610
Depreciation and amortization                      
Total                 887 922 949
Expenditures for long-lived assets                      
Total                 641 506 557
Corporate                      
Operating profit                      
Operating income                 0 (1,113) (104)
Depreciation and amortization                      
Total                 125 136 122
Expenditures for long-lived assets                      
Total                 104 120 125
U.S. Pharmaceutical                      
Segment revenues (1)                      
Revenues                 189,274 181,700 166,189
U.S. Pharmaceutical | Operating Segments                      
Operating profit                      
Operating income                 2,763 2,745 2,710
Depreciation and amortization                      
Total                 211 208 227
Expenditures for long-lived assets                      
Total                 246 109 103
International                      
Segment revenues (1)                      
Revenues                 35,965 38,341 38,023
International | Operating Segments                      
Operating profit                      
Operating income                 (37) (161) (1,903)
Depreciation and amortization                      
Total                 334 357 392
Expenditures for long-lived assets                      
Total                 212 218 199
Medical-Surgical Solutions                      
Segment revenues (1)                      
Revenues                 10,099 8,305 7,618
Medical-Surgical Solutions | Operating Segments                      
Operating profit                      
Operating income                 707 499 455
Depreciation and amortization                      
Total                 130 136 118
Expenditures for long-lived assets                      
Total                 57 36 116
Prescription Technology Solutions                      
Segment revenues (1)                      
Revenues                 2,890 2,705 2,489
Prescription Technology Solutions | Operating Segments                      
Operating profit                      
Operating income                 395 396 355
Depreciation and amortization                      
Total                 87 85 90
Expenditures for long-lived assets                      
Total                 $ 22 $ 23 $ 14